SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astal Laboratories - Quaterly Results

12 Aug 2025 Evaluate
An increase of about 92.66% to Rs. 253.27 millions in the topline was observed for the quarter ended June 2025. The topline stood at Rs. 131.46 millions during the similar quarter previous year.Net profit stood at Rs. 20.90  millions  compared to Rs. 16.89 millions in the corresponding previous quarter,high by 23.74%.Operating profit for the quarter ended June 2025 rose to 32.14 millions as compared to 24.14 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 253.27 131.46 92.66 253.27 131.46 92.66 642.31 236.48 171.61
Other Income 0.56 0.34 64.71 0.56 0.34 64.71 1.25 0.13 861.54
PBIDT 32.14 24.14 33.14 32.14 24.14 33.14 129.02 11.28 1043.79
Interest 3.01 0.63 377.78 3.01 0.63 377.78 7.01 0.11 6272.73
PBDT 29.13 23.51 23.90 29.13 23.51 23.90 122.01 11.17 992.30
Depreciation 1.20 0.13 823.08 1.20 0.13 823.08 2.23 0.30 643.33
PBT 27.93 23.38 19.46 27.93 23.38 19.46 119.78 10.87 1001.93
TAX 7.03 6.49 8.32 7.03 6.49 8.32 30.52 3.02 910.60
Deferred Tax 2.47 0.26 850.00 2.47 0.26 850.00 1.11 0.08 1287.50
PAT 20.90 16.89 23.74 20.90 16.89 23.74 89.26 7.85 1037.07
Equity 98.46 98.46 0.00 98.46 98.46 0.00 98.46 98.46 0.00
PBIDTM(%) 12.69 18.36 -30.89 12.69 18.36 -30.89 20.09 4.77 321.11

Astal Laboratories Share Price

63.10 1.58 (2.57%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×